Zhang, F., Sahu, V., Peng, K., Wang, Y., Li, T., Bala, P., Aitymbayev, D., Sahgal, P., Schaefer, A., Der, C. J., Ryeom, S., Yoon, S., Sethi, N., Bass, A. J., & Zhang, H. (2024). Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer. Gut, 73(8), 1280–1291. https://doi.org/10.1136/gutjnl-2023-329686

Buckley, K. H., Beyries, K. A., Ryeom, S., Yoon, S. S., & Katona, B. W. (2024). Establishment and Characterization of Patient-derived Gastric Organoids from Biopsies of Benign Gastric Body and Antral Epithelium. Journal of Visualized Experiments, 203. https://doi.org/10.3791/66094

Koerner, A. S., Zhou, M., Brook, A., Yoon, S. S., & Ganjoo, K. N. (2023). Response to Immunotherapy in Sclerosing Epithelioid Fibrosarcoma: Case Report and Literature Review. Cureus. https://doi.org/10.7759/cureus.50967

Wu, S. P., Keshavjee, S. H., Yoon, S. S., & Kwon, S. (2023). Survival Outcomes and Patterns of Care for Stage II or III Resected Gastric Cancer by Race and Ethnicity. JAMA Network Open, 6(12), e2349026. https://doi.org/10.1001/jamanetworkopen.2023.49026

Koerner, A. S., Moy, R. H., Ryeom, S. W., & Yoon, S. S. (2023). The Present and Future of Neoadjuvant and Adjuvant Therapy for Locally Advanced Gastric Cancer. Cancers, 15(16), 4114. https://doi.org/10.3390/cancers15164114

Yoon, C., Lu, J., Jun, Y., Suh, Y.-S., Kim, B.-J., Till, J. E., Kim, J. H., Keshavjee, S. H., Ryeom, S., & Yoon, S. S. (2023). RETRACTED ARTICLE: KRAS activation in gastric cancer stem-like cells promotes tumor angiogenesis and metastasis. BMC Cancer, 23(1). https://doi.org/10.1186/s12885-023-11170-0

Rust, D. J., Kwinta, B. D., Geskin, L. J., Samie, F. H., Remotti, F., & Yoon, S. S. (2023). Surgical management of dermatofibrosarcoma protuberans. Journal of Surgical Oncology, 128(1), 87–96. Portico. https://doi.org/10.1002/jso.27258

Yoon, C., Lu, J., Kim, B.-J., Cho, S.-J., Kim, J. H., Moy, R. H., Ryeom, S. W., & Yoon, S. S. (2023). Patient-Derived Organoids from Locally Advanced Gastric Adenocarcinomas Can Predict Resistance to Neoadjuvant Chemotherapy. Journal of Gastrointestinal Surgery, 27(4), 666–676. https://doi.org/10.1007/s11605-022-05568-7

Minikes, A. M., Song, Y., Feng, Y., Yoon, C., Yoon, S. S., & Jiang, X. (2023). E-cadherin is a biomarker for ferroptosis sensitivity in diffuse gastric cancer. Oncogene, 42(11), 848–857. https://doi.org/10.1038/s41388-023-02599-5

Stillman, M. D., Kusche, N., Toledano, S., Hilfrank, K. J., Yoon, C., Gabre, J. T., Rustgi, S. D., Hur, C., Kastrinos, F., Ryeom, S. W., & Yoon, S. S. (2022). Short and long‐term outcomes of prophylactic total gastrectomy in 54 consecutive individuals with germline pathogenic mutations in the CDH1 gene. Journal of Surgical Oncology, 126(8), 1413–1422. Portico. https://doi.org/10.1002/jso.27084

Keshavjee, S. H., Moy, R. H., Reiner, S. L., Ryeom, S. W., & Yoon, S. S. (2022). Gastric Cancer and the Immune System: The Key to Improving Outcomes? Cancers, 14(23), 5940. https://doi.org/10.3390/cancers14235940

Rust, D. J., Kato, T., & Yoon, S. S. (2022). Treatment for local control of retroperitoneal and pelvis sarcomas: A review of the literature. Surgical Oncology, 43, 101814. https://doi.org/10.1016/j.suronc.2022.101814

Stillman, M. D., & Yoon, S. S. (2022). Open and minimally invasive gastrectomy in Eastern and Western patient populations: A review of the literature and reasons for differences in outcomes. Journal of Surgical Oncology, 126(2), 279–291. Portico. https://doi.org/10.1002/jso.26887